ON
Oncopeptides
Latest price
1.74 SEK
17/09/2026
ONCO
3 mo
6 mo+78.16%1 price targets
1 yr+78.16%1 price targets
Max 2 price targets
HealthcareBiotechnology
Overview
Analysts
About The Company
Oncopeptides AB is a Swedish pharmaceutical company that develops drugs for the treatment of cancer. It was founded in 2000, based on cancer research and supported by Healthcap, Industrifonden and Karolinska Institutet. Oncopeptode’s shares have been listed on the Stockholm Stock Exchange’s main list since 2017.
Wikipedia
Consensus
Consensus
2.55 SEK
Upside
+46.55%
Based on older targets - no fresh targets in the last 90 days.
Latest price1.74 SEK
Insider Trades for Oncopeptides
No insider trades for the selected period.
